SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Patricia M. Chege, Gawain McColl, Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  2. 2
    Jin Yong Hong, Hyuk Jin Yun, Mun Kyung Sunwoo, Jee Hyun Ham, Jong-Min Lee, Young H. Sohn, Phil Hyu Lee, Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 9, 999

    CrossRef

  3. 3
    H. C. V. Pfeiffer, A. Løkkegaard, M. Zoetmulder, L. Friberg, L. Werdelin, Cognitive impairment in early-stage non-demented Parkinson's disease patients, Acta Neurologica Scandinavica, 2014, 129, 5
  4. 4
    Roberta Biundo, Luca Weis, Silvia Facchini, Patrizia Formento-Dojot, Annamaria Vallelunga, Manuela Pilleri, Angelo Antonini, Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia, Parkinsonism & Related Disorders, 2014, 20, 4, 394

    CrossRef

  5. 5
    John V. Hindle, Anthony Martyr, Linda Clare, Cognitive reserve in Parkinson's disease: A systematic review and meta-analysis, Parkinsonism & Related Disorders, 2014, 20, 1, 1

    CrossRef

  6. 6
    Bàrbara Segura, Hugo César Baggio, Maria Josep Marti, Francesc Valldeoriola, Yaroslau Compta, Anna Isabel Garcia-Diaz, Pere Vendrell, Núria Bargallo, Eduardo Tolosa, Carme Junque, Cortical thinning associated with mild cognitive impairment in Parkinson's disease, Movement Disorders, 2014, 29, 9
  7. 7
    Atsuko Nagano-Saito, Claudine Habak, Beatriz Mejía-Constaín, Clotilde Degroot, Laura Monetta, Thomas Jubault, Christophe Bedetti, Anne-Louise Lafontaine, Sylvain Chouinard, Valérie Soland, Alain Ptito, Antonio P. Strafella, Oury Monchi, Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease, Neurobiology of Aging, 2014, 35, 1, 223

    CrossRef

  8. 8
    J. E. Lee, K. H. Cho, S. K. Song, H. J. Kim, H. S. Lee, Y. H. Sohn, P. H. Lee, Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 1, 7

    CrossRef

  9. 9
    Hugo-Cesar Baggio, Roser Sala-Llonch, Bàrbara Segura, Maria-José Marti, Francesc Valldeoriola, Yaroslau Compta, Eduardo Tolosa, Carme Junqué, Functional brain networks and cognitive deficits in Parkinson's disease, Human Brain Mapping, 2014, 35, 9
  10. 10
    C. Nombela, J. B. Rowe, S. E. Winder-Rhodes, A. Hampshire, A. M. Owen, D. P. Breen, G. W. Duncan, T. K. Khoo, A. J. Yarnall, M. J. Firbank, P. F. Chinnery, T. W. Robbins, J. T. O'Brien, D. J. Brooks, D. J. Burn, R. A. Barker, Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study, Brain, 2014,

    CrossRef

  11. 11
    R. Gonzalez-Redondo, D. Garcia-Garcia, P. Clavero, C. Gasca-Salas, R. Garcia-Eulate, J. L. Zubieta, J. Arbizu, J. A. Obeso, M. C. Rodriguez-Oroz, Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process, Brain, 2014, 137, 8, 2356

    CrossRef

  12. 12
    Yuko Koshimori, Barbara Segura, Leigh Christopher, Nancy Lobaugh, Sarah Duff-Canning, Romina Mizrahi, Clement Hamani, Anthony E. Lang, Kelly Aminian, Sylvain Houle, Antonio P. Strafella, Imaging changes associated with cognitive abnormalities in Parkinson’s disease, Brain Structure and Function, 2014,

    CrossRef

  13. 13
    Han-Joon Kim, Beom S. Jeon, Sun Ha Paek, Kyoung-Min Lee, Ji-Young Kim, Jee-Young Lee, Hee Jin Kim, Ji Young Yun, Young Eun Kim, Hui-Jun Yang, Gwanhee Ehm, Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson’s disease, Journal of Neurology, 2014, 261, 6, 1090

    CrossRef

  14. 14
    Urban Ekman, Johan Eriksson, Lars Forsgren, Magdalena E. Domellöf, Eva Elgh, Anders Lundquist, Lars Nyberg, Longitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment, Frontiers in Neuroscience, 2014, 8,

    CrossRef

  15. 15
    Emilia J. Sitek, Jarosław Sławek, Jonathan J. Evans, Mild cognitive impairment in Parkinson's disease: How much testing is needed for correct diagnosis?, Basal Ganglia, 2014,

    CrossRef

  16. 16
    A. Bottini Bonfanti, More than movement: the importance of the evolution of mild cognitive impairment in Parkinson's disease, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 1, 2

    CrossRef

  17. 17
    Michele T. M. Hu, Konrad Szewczyk-Królikowski, Paul Tomlinson, Kannan Nithi, Michal Rolinski, Clara Murray, Kevin Talbot, Klaus P. Ebmeier, Clare E. Mackay, Yoav Ben-Shlomo, Predictors of cognitive impairment in an early stage Parkinson's disease cohort, Movement Disorders, 2014, 29, 3
  18. 18
    Johann Lehrner, Heidemarie Zach, Doris Moser, Andreas Gleiß, Eduard Auff, Walter Pirker, Gisela Pusswald, Prevalence of Mild Cognitive Impairment Subtypes in Patients with Parkinson’s Disease – Comparison of two Modes of Classification, Zeitschrift für Neuropsychologie, 2014, 25, 1, 49

    CrossRef

  19. 19
    Jin Yong Hong, Mun Kyung Sunwoo, Seok Jong Chung, Jee Hyun Ham, Ji E. Lee, Young H. Sohn, Phil Hyu Lee, Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease, Neurobiology of Aging, 2014, 35, 7, 1739

    CrossRef

  20. 20
    Aristide Merola, Laura Rizzi, Carlo Alberto Artusi, Maurizio Zibetti, Mario Giorgio Rizzone, Alberto Romagnolo, Andrea Bernardini, Michele Lanotte, Leonardo Lopiano, Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients, Journal of Neurology, 2014,

    CrossRef

  21. 21
    M. K. Sunwoo, S. Jeon, J. H. Ham, J. Y. Hong, J. E. Lee, J.-M. Lee, Y. H. Sohn, P. H. Lee, The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease, European Journal of Neurology, 2014, 21, 6
  22. 22
    Jennifer G. Goldman, Caroline Williams-Gray, Roger A. Barker, John E. Duda, James E. Galvin, The spectrum of cognitive impairment in Lewy body diseases, Movement Disorders, 2014, 29, 5
  23. 23
    Connie Marras, Alexander I. Tröster, Jaime Kulisevsky, Glenn T. Stebbins, The tools of the trade: A state of the art “How to Assess Cognition” in the patient with Parkinson's disease, Movement Disorders, 2014, 29, 5
  24. 24
    Barbara Connolly, Susan H. Fox, Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson’s Disease, Neurotherapeutics, 2014, 11, 1, 78

    CrossRef

  25. 25
    Alison J Yarnall, What are the priorities in Parkinson's disease clinical research? A focus on motor complications, gait and cognition, Neurodegenerative Disease Management, 2014, 4, 2, 127

    CrossRef

  26. 26
    Joong-Seok Kim, Wooyoung Jang, Jin Whan Cho, Jin Young Ahn, Hee-Tae Kim, Bedside cognitive assessments and falls risk in Parkinson’s disease, Neurological Sciences, 2013, 34, 1, 75

    CrossRef

  27. 27
    Mona K. Beyer, Guido Alves, Kristy S. Hwang, Sona Babakchanian, Kolbjorn S. Bronnick, Yi-Yu Chou, Turi O. Dalaker, Martin W. Kurz, Jan P. Larsen, Johanne H. Somme, Paul M. Thompson, Ole-Bjørn Tysnes, Liana G. Apostolova, Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease, Movement Disorders, 2013, 28, 3
  28. 28
    Kim T.E. Olde Dubbelink, Diederick Stoffers, Jan Berend Deijen, Jos W.R. Twisk, Cornelis J. Stam, Henk W. Berendse, Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study, Neurobiology of Aging, 2013, 34, 2, 408

    CrossRef

  29. 29
    Jennifer G. Goldman, Samantha Holden, Bryan Bernard, Bichun Ouyang, Christopher G. Goetz, Glenn T. Stebbins, Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease, Movement Disorders, 2013, 28, 14
  30. 30
    V. Isella, C. Mapelli, N. Morielli, C. Siri, D. De Gaspari, G. Pezzoli, A. Antonini, M. Poletti, U. Bonuccelli, L. Picchi, A. Napolitano, M. Vista, I.M. Appollonio, Diagnosis of possible Mild Cognitive Impairment in Parkinson's disease: Validity of the SCOPA-Cog, Parkinsonism & Related Disorders, 2013, 19, 12, 1160

    CrossRef

  31. 31
    Jennifer G. Goldman, Reena A. Ghode, Bichun Ouyang, Bryan Bernard, Christopher G. Goetz, Glenn T. Stebbins, Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 9, 806

    CrossRef

  32. 32
    Raffaele Nardone, Jürgen Bergmann, Francesco Brigo, Monica Christova, Alexander Kunz, Martin Seidl, Frediano Tezzon, Eugen Trinka, Stefan Golaszewski, Functional evaluation of central cholinergic circuits in patients with Parkinson’s disease and REM sleep behavior disorder: a TMS study, Journal of Neural Transmission, 2013, 120, 3, 413

    CrossRef

  33. 33
    Lewis Pettit, Martina McCarthy, Richard Davenport, Sharon Abrahams, Heterogeneity of Letter Fluency Impairment and Executive Dysfunction in Parkinson's Disease, Journal of the International Neuropsychological Society, 2013, 19, 09, 986

    CrossRef

  34. 34
    R. Marin, J.A. Rojo, N. Fabelo, C.E. Fernandez, M. Diaz, Lipid raft disarrangement as a result of neuropathological progresses: A novel strategy for early diagnosis?, Neuroscience, 2013, 245, 26

    CrossRef

  35. 35
    Kun Nie, Yuhu Zhang, Biao Huang, Limin Wang, Jiehao Zhao, Zhiheng Huang, Rong Gan, Lijuan Wang, Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment, Parkinsonism & Related Disorders, 2013, 19, 3, 329

    CrossRef

  36. 36
    Connie Marras, Melissa J. Armstrong, Christopher A. Meaney, Susan Fox, Brandon Rothberg, William Reginold, David F. Tang-Wai, David Gill, Paul J. Eslinger, Cindy Zadikoff, Nancy Kennedy, Fred J. Marshall, Mark Mapstone, Kelvin L. Chou, Carol Persad, Irene Litvan, Benjamin T. Mast, Adam T. Gerstenecker, Sandra Weintraub, Sarah Duff-Canning, Measuring mild cognitive impairment in patients with Parkinson's disease, Movement Disorders, 2013, 28, 5
  37. 37
    Kurt A. Jellinger, Mild cognitive impairment in Parkinson disease: heterogenous mechanisms, Journal of Neural Transmission, 2013, 120, 1, 157

    CrossRef

  38. 38
    A. J. Yarnall, L. Rochester, D. J. Burn, Mild cognitive impairment in Parkinson's disease, Age and Ageing, 2013, 42, 5, 567

    CrossRef

  39. 39
    Amos D. Korczyn, Mild cognitive impairment in Parkinson’s disease, Journal of Neural Transmission, 2013, 120, 4, 517

    CrossRef

  40. 40
    Natalie C. Palavra, Sharon L. Naismith, Simon J. G. Lewis, Mild Cognitive Impairment in Parkinson’s Disease: A Review of Current Concepts, Neurology Research International, 2013, 2013, 1

    CrossRef

  41. 41
    Alexandru Hanganu, Christophe Bedetti, Thomas Jubault, Jean-Francois Gagnon, Béatriz Mejia-Constain, Clotilde Degroot, Anne-Louise Lafontaine, Sylvain Chouinard, Oury Monchi, Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration, Movement Disorders, 2013, 28, 10
  42. You have free access to this content42
    Leigh Christopher, Antonio P. Strafella, Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease, Journal of Neuropsychology, 2013, 7, 2
  43. 43
    G. W. Duncan, A. J. Yarnall, S. Marrinan, D. J. Burn, New horizons in the pathogenesis, assessment and management of movement disorders, Age and Ageing, 2013, 42, 1, 2

    CrossRef

  44. 44
    Amit Sindhi, Iracema Leroi, Nonpharmacological therapies for cognitive enhancement in Parkinson’s disease: applying old interventions in a new setting?, Neurodegenerative Disease Management, 2013, 3, 6, 539

    CrossRef

  45. 45
    Ramón Fernández de Bobadilla, Javier Pagonabarraga, Saül Martínez-Horta, Berta Pascual-Sedano, Antonia Campolongo, Jaime Kulisevsky, Parkinson's disease-cognitive rating scale: Psychometrics for mild cognitive impairment, Movement Disorders, 2013, 28, 10
  46. 46
    Aleksandra Kudlicka, Linda Clare, John V. Hindle, Pattern of Executive Impairment in Mild to Moderate Parkinson's Disease, Dementia and Geriatric Cognitive Disorders, 2013, 36, 1-2, 50

    CrossRef

  47. 47
    Rwei-Ling Yu, Ruey-Meei Wu, Social brain dysfunctions in patients with Parkinson’s disease: a review of theory of mind studies, Translational Neurodegeneration, 2013, 2, 1, 7

    CrossRef

  48. 48
    N. K. Archibald, S. B. Hutton, M. P. Clarke, U. P. Mosimann, D. J. Burn, Visual exploration in Parkinson's disease and Parkinson's disease dementia, Brain, 2013, 136, 3, 739

    CrossRef

  49. 49
    Thien Thien Lim, Kelvin L. Chou, Hubert H. Fernandez, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  50. 50
    Julie Fields, Alexander Tröster, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  51. 51
    Julie A. Fields, Alexander I. Tröster, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  52. 52
    Thien Lim, Kelvin Chou, Hubert Fernandez, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  53. 53
    Kun Nie, Yuhu Zhang, Limin Wang, Jiehao Zhao, Zhiheng Huang, Rong Gan, Shaohua Li, Lijuan Wang, A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson’s disease in China, Journal of Clinical Neuroscience, 2012, 19, 11, 1497

    CrossRef

  54. 54
    Valerie E. Kelly, Alexis J. Eusterbrock, Anne Shumway-Cook, A Review of Dual-Task Walking Deficits in People with Parkinson's Disease: Motor and Cognitive Contributions, Mechanisms, and Clinical Implications, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  55. 55
    D. Weintraub, N. Dietz, J. E. Duda, D. A. Wolk, J. Doshi, S. X. Xie, C. Davatzikos, C. M. Clark, A. Siderowf, Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease, Brain, 2012, 135, 1, 170

    CrossRef

  56. 56
    Jennifer G. Goldman, Holly Weis, Glenn Stebbins, Bryan Bernard, Christopher G. Goetz, Clinical differences among mild cognitive impairment subtypes in Parkinson's disease, Movement Disorders, 2012, 27, 9
  57. 57
    Iddo Magen, Sheila M. Fleming, Chunni Zhu, Eddie C. Garcia, Katherine M. Cardiff, Diana Dinh, Krystal De La Rosa, Maria Sanchez, Eileen Ruth Torres, Eliezer Masliah, J. David Jentsch, Marie-Françoise Chesselet, Cognitive deficits in a mouse model of pre-manifest Parkinson’s disease, European Journal of Neuroscience, 2012, 35, 6
  58. 58
    Javier Pagonabarraga, Jaime Kulisevsky, Cognitive impairment and dementia in Parkinson's disease, Neurobiology of Disease, 2012, 46, 3, 590

    CrossRef

  59. 59
    Per Svenningsson, Eric Westman, Clive Ballard, Dag Aarsland, Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment, The Lancet Neurology, 2012, 11, 8, 697

    CrossRef

  60. 60
    Qi Wu, Ling Chen, Yifan Zheng, Caixia Zhang, Linhuan Huang, Wenyuan Guo, Yingying Fang, Hongyan Zhou, Yanmei Liu, Jie Chen, Hao Qian, Wenbiao Xian, Jinsheng Zeng, Jinru Li, Zhuolin Liu, Zhong Pei, Cognitive impairment is common in Parkinson’s disease without dementia in the early and middle stages in a Han Chinese cohort, Parkinsonism & Related Disorders, 2012, 18, 2, 161

    CrossRef

  61. 61
    J.H. Liu, X.S. Li, J. Ye, L.H. Gao, Z.P. Zhang, W. Wu, L. Yao, J. Zhang, Cognitive impairments in Parkinson's disease, Aging & Mental Health, 2012, 16, 4, 529

    CrossRef

  62. 62
    Hyun Jin Yoon, Sang Myung Cheon, Young Jin Jeong, Do-Young Kang, Correlated regions of cerebral blood flow with clinical parameters in Parkinson’s disease; comparison using ‘Anatomy’ and ‘Talairach Daemon’ software, Annals of Nuclear Medicine, 2012, 26, 2, 164

    CrossRef

  63. 63
    Hyun Jin Yoon, Kyung Won Park, Young Jin Jeong, Do-Young Kang, Correlation between neuropsychological tests and hypoperfusion in MCI patients: anatomical labeling using xjView and Talairach Daemon Software, Annals of Nuclear Medicine, 2012, 26, 8, 656

    CrossRef

  64. 64
    Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster, Ben A. Schmand, Daniel Weintraub, Ronald C. Petersen, Brit Mollenhauer, Charles H. Adler, Karen Marder, Caroline H. Williams-Gray, Dag Aarsland, Jaime Kulisevsky, Maria C. Rodriguez-Oroz, David J. Burn, Roger A. Barker, Murat Emre, Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines, Movement Disorders, 2012, 27, 3
  65. 65
    I. P. Miah, K. T. Olde Dubbelink, D. Stoffers, J. B. Deijen, H. W. Berendse, Early-stage cognitive impairment in Parkinson’s disease and the influence of dopamine replacement therapy, European Journal of Neurology, 2012, 19, 3
  66. 66
    Liana Apostolova, Guido Alves, Kristy S. Hwang, Sona Babakchanian, Kolbjorn S. Bronnick, Jan Petter Larsen, Paul M. Thompson, Yi-Yu Chou, Ole B. Tysnes, Hege K. Vefring, Mona K. Beyer, Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment, Neurobiology of Aging, 2012, 33, 9, 2113

    CrossRef

  67. 67
    Oury Monchi, A Jon Stoessl, Imaging neural correlates of mild cognitive impairment in Parkinson's disease, The Lancet Neurology, 2012, 11, 8, 653

    CrossRef

  68. 68
    Roberto Erro, Gabriella Santangelo, Marina Picillo, Carmine Vitale, Marianna Amboni, Katia Longo, Angela Costagliola, Maria Teresa Pellecchia, Roberto Allocca, Anna Rosa, Giuseppe Michele, Lucio Santoro, Paolo Barone, Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients, Journal of Neurology, 2012, 259, 9, 1808

    CrossRef

  69. 69
    Elliott J. Mufson, Lester Binder, Scott E. Counts, Steven T. DeKosky, Leyla deToledo-Morrell, Stephen D. Ginsberg, Milos D. Ikonomovic, Sylvia E. Perez, Stephen W. Scheff, Mild cognitive impairment: pathology and mechanisms, Acta Neuropathologica, 2012, 123, 1, 13

    CrossRef

  70. 70
    Kurt A Jellinger, Neurobiology of cognitive impairment in Parkinson’s disease, Expert Review of Neurotherapeutics, 2012, 12, 12, 1451

    CrossRef

  71. 71
    Jin Yong Hong, Ji Eun Lee, Young H. Sohn, Phil Hyu Lee, Neurocognitive and atrophic patterns in Parkinson’s disease based on subjective memory complaints, Journal of Neurology, 2012, 259, 8, 1706

    CrossRef

  72. 72
    Iracema Leroi, Hiranmayi Pantula, Kathryn McDonald, Vijay Harbishettar, Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  73. 73
    Rwei-Ling Yu, Ruey-Meei Wu, Chun-Hwei Tai, Chin-Hsien Lin, Ting-Wen Cheng, Mau-Sun Hua, Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan, Parkinsonism & Related Disorders, 2012, 18, 10, 1067

    CrossRef

  74. 74
    David Garcia-Garcia, Pedro Clavero, Carmen Gasca Salas, Isabel Lamet, Javier Arbizu, Rafael Gonzalez-Redondo, Jose A. Obeso, Maria C. Rodriguez-Oroz, Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease, European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39, 11, 1767

    CrossRef

  75. 75
    Jonas Jardim de Paula, Marco Túlio Gualberto Cintra, Débora Marques Miranda, Maria Aparecida Camargos Bicalho, Edgar Nunes Moares, Leandro Fernandes Malloy-Diniz, Remission of Cognitive Deficits in Parkinson’s Disease: Recovery from a Nonamnestic Mild Cognitive Impairment or Psychiatric Symptoms Remission?, Case Reports in Psychiatry, 2012, 2012, 1

    CrossRef

  76. 76
    Hyun Jin Yoon, Kyung Won Park, Young Jin Jeong, Do-Young Kang, Significant correlation between cerebral hypoperfusion and neuropsychological assessment scores of patients with mild cognitive impairment, Nuclear Medicine Communications, 2012, 33, 8, 848

    CrossRef

  77. 77
    Javier Pagonabarraga, Beatriz Gómez-Ansón, Ramon Rotger, Gisela Llebaria, Carmen García-Sánchez, Berta Pascual-Sedano, Alexandre Gironell, Manuel Delfino, Jaume Ruscalleda, Jaime Kulisevsky, Spectroscopic Changes Associated with Mild Cognitive Impairment and Dementia in Parkinson’s Disease, Dementia and Geriatric Cognitive Disorders, 2012, 34, 5-6, 312

    CrossRef

  78. 78
    Vikas Kotagal, Martijn L.T.M. Müller, Daniel I. Kaufer, Robert A. Koeppe, Nicolaas I. Bohnen, Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders, Neuroscience Letters, 2012, 514, 2, 169

    CrossRef

  79. 79
    William Reginold, Melissa J. Armstrong, Sarah Duff-Canning, Anthony Lang, David Tang-Wai, Susan Fox, Brandon Rothberg, Cindy Zadikoff, Nancy Kennedy, David Gill, Paul Eslinger, Mark Mapstone, Kelvin Chou, Carol Persad, Irene Litvan, Benjamin Mast, Connie Marras, The pill questionnaire in a nondemented Parkinson's disease population, Movement Disorders, 2012, 27, 10
  80. 80
    Daniel O. Claassen, Scott A. Wylie, Trends and Issues in Characterizing Early Cognitive Changes in Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2012, 12, 6, 695

    CrossRef

  81. 81
    Seo Hee Choi, Tae Min Jung, Ji E. Lee, Seung-Koo Lee, Young H. Sohn, Phil Hyu Lee, Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status, Neurobiology of Aging, 2012, 33, 7, 1265

    CrossRef

  82. 82
    Liana G. Apostolova, Steven T. DeKosky, Jeffrey L. Cummings, Neurology in Clinical Practice, 2012,

    CrossRef

  83. 83
    Anna Prats París, Heidi Guerra Saleta, Maria de la Cruz Crespo Maraver, Emmanuel Silvestre, Maite Garolera Freixa, Cristina Petit Torrellas, Silvia Alonso Pont, Marc Fabra Nadal, Sheila Alcaine Garcia, Maria Victoria Perea Bartolomé, Valentina Ladera Fernández, Àngels Rusiñol Bayés, Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease, Movement Disorders, 2011, 26, 7
  84. 84
    John C. Dalrymple-Alford, Leslie Livingston, Michael R. MacAskill, Charlotte Graham, Tracy R. Melzer, Richard J. Porter, Richard Watts, Tim J. Anderson, Characterizing mild cognitive impairment in Parkinson's disease, Movement Disorders, 2011, 26, 4
  85. 85
    Nina Schlede, Ronan Zimmermann, Michael M. Ehrensperger, Ute Gschwandtner, Martin Hardmeier, Florian Hatz, Andreas U. Monsch, Yvonne Naegelin, Peter Fuhr, Clinical EEG in cognitively impaired patients with Parkinson's Disease, Journal of the Neurological Sciences, 2011, 310, 1-2, 75

    CrossRef

  86. 86
    Paolo Barone, Dag Aarsland, David Burn, Murat Emre, Jaime Kulisevsky, Daniel Weintraub, Cognitive impairment in nondemented Parkinson's disease, Movement Disorders, 2011, 26, 14
  87. 87
    Kam-Mei Lau, Alma Au, Correlates of Informal Caregiver Distress in Parkinson's Disease: A Meta-Analysis, Clinical Gerontologist, 2011, 34, 2, 117

    CrossRef

  88. 88
    Sharon L. Naismith, Marilia Pereira, James M. Shine, Simon J.G. Lewis, How well do caregivers detect mild cognitive change in Parkinson's disease?, Movement Disorders, 2011, 26, 1
  89. 89
    Inga Liepelt-Scarfone, Susanne Graeber, Anne Feseker, Gülsüm Baysal, Jana Godau, Alexandra Gaenslen, Walter Maetzler, Daniela Berg, Influence of Different Cut-Off Values on the Diagnosis of Mild Cognitive Impairment in Parkinson's Disease, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  90. 90
    Saül Martínez-Horta, Jaime Kulisevsky, Is all cognitive impairment in Parkinson’s disease “mild cognitive impairment”?, Journal of Neural Transmission, 2011, 118, 8, 1185

    CrossRef

  91. 91
    Irene Litvan, Dag Aarsland, Charles H. Adler, Jennifer G. Goldman, Jaime Kulisevsky, Brit Mollenhauer, Maria C. Rodriguez-Oroz, Alexander I. Tröster, Daniel Weintraub, MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI, Movement Disorders, 2011, 26, 10
  92. 92
    Michele Poletti, Murat Emre, Ubaldo Bonuccelli, Mild cognitive impairment and cognitive reserve in Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 8, 579

    CrossRef

  93. 93
    Irena Rektorova, Mild cognitive impairment exists in Parkinson’s disease, Journal of Neural Transmission, 2011, 118, 8, 1179

    CrossRef

  94. 94
    Angela Costello, Hadeel Al Khamees, John Moriarty, Natasha Hulse, Irfan Malik, Richard Selway, Chris Clough, Keyoumars Ashkan, Michael Samuel, Non-amnestic mild cognitive impairment is a prominent aspect in Parkinson’s disease patients being considered for deep brain stimulation, Basal Ganglia, 2011, 1, 4, 213

    CrossRef

  95. 95
    Daniel Weintraub, David J. Burn, Parkinson's disease: The quintessential neuropsychiatric disorder, Movement Disorders, 2011, 26, 6
  96. 96
    Sook K. Song, Ji E. Lee, Hae-Jeong Park, Young H. Sohn, Jong Doo Lee, Phil Hyu Lee, The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status, Movement Disorders, 2011, 26, 2
  97. 97
    Thomas Benke, The role of neuropsychology in prodromal dementia, Neurodegenerative Disease Management, 2011, 1, 4, 323

    CrossRef

  98. 98
    Natalie C. Komadina, Zoe Terpening, Yue Huang, Glenda M. Halliday, Sharon L. Naismith, Simon J.G. Lewis, Utility and Limitations of Addenbrooke’s Cognitive Examination-Revised for Detecting Mild Cognitive Impairment in Parkinson’s Disease, Dementia and Geriatric Cognitive Disorders, 2011, 31, 5, 349

    CrossRef

  99. 99
    Sylvia Villeneuve, Jessica Rodrigues-Brazète, Steve Joncas, Ronald B. Postuma, Véronique Latreille, Jean-François Gagnon, Validity of the Mattis Dementia Rating Scale to Detect Mild Cognitive Impairment in Parkinson’s Disease and REM Sleep Behavior Disorder, Dementia and Geriatric Cognitive Disorders, 2011, 31, 3, 210

    CrossRef

  100. 100
    Richard Camicioli, Jennifer Sabino, Myrlene Gee, Thomas Bouchard, Nancy Fisher, Chris Hanstock, Derek Emery, W.R. Wayne Martin, Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia, Movement Disorders, 2011, 26, 8
  101. 101
    Turi O. Dalaker, Robert Zivadinov, Deepa Preeti Ramasamy, Mona K. Beyer, Guido Alves, Kolbjorn S. Bronnick, Ole-Bjorn Tysnes, Dag Aarsland, Jan P. Larsen, Ventricular enlargement and mild cognitive impairment in early Parkinson's disease, Movement Disorders, 2011, 26, 2
  102. 102
    Karen Marder, Cognitive impairment and dementia in Parkinson's disease, Movement Disorders, 2010, 25, S1
  103. 103
    Javier Rodríguez-Ferreiro, Fernando Cuetos, Elena Herrera, Manuel Menéndez, Renée Ribacoba, Cognitive impairment in Parkinson's disease without dementia, Movement Disorders, 2010, 25, 13
  104. 104
    D. A. Stepkina, V. V. Zakharov, N. N. Yakhno, Cognitive Impairments in Progression of Parkinson’s Disease, Neuroscience and Behavioral Physiology, 2010, 40, 1, 61

    CrossRef

  105. 105
    Y. Nishio, K. Hirayama, A. Takeda, Y. Hosokai, T. Ishioka, K. Suzuki, Y. Itoyama, S. Takahashi, E. Mori, Corticolimbic gray matter loss in Parkinson’s disease without dementia, European Journal of Neurology, 2010, 17, 8
  106. 106
    Kumar M Prakash, Eng-King Tan, Development of Parkinson’s disease biomarkers, Expert Review of Neurotherapeutics, 2010, 10, 12, 1811

    CrossRef

  107. 107
    Mark J. Millan, From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease, Pharmacology & Therapeutics, 2010, 128, 2, 229

    CrossRef

  108. 108
    Turi O. Dalaker, Robert Zivadinov, Jan P. Larsen, Mona K. Beyer, Jennifer L. Cox, Guido Alves, Kolbjorn Bronnick, Ole-Bjorn Tysnes, Ronald Antulov, Michael G. Dwyer, Dag Aarsland, Gray matter correlations of cognition in incident Parkinson's disease, Movement Disorders, 2010, 25, 5
  109. 109
    Charles H. Adler, John N. Caviness, Marwan N. Sabbagh, Holly A. Shill, Donald J. Connor, Lucia Sue, Virgilio G. H. Evidente, Erika Driver-Dunckley, Thomas G. Beach, Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment, Acta Neuropathologica, 2010, 120, 6, 827

    CrossRef

  110. 110
    Liana G. Apostolova, Mona Beyer, Amity E. Green, Kristy S. Hwang, Jonathan H. Morra, Yi-Yu Chou, Christina Avedissian, Dag Aarsland, Carmen C. Janvin, Jan P. Larsen, Jeffrey L. Cummings, Paul M. Thompson, Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia, Movement Disorders, 2010, 25, 6
  111. 111
    Ann B. Sollinger, Felicia C. Goldstein, James J. Lah, Allan I. Levey, Stewart A. Factor, Mild cognitive impairment in Parkinson's disease: Subtypes and motor characteristics, Parkinsonism & Related Disorders, 2010, 16, 3, 177

    CrossRef

  112. 112
    Angie A Kehagia, Roger A Barker, Trevor W Robbins, Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease, The Lancet Neurology, 2010, 9, 12, 1200

    CrossRef

  113. 113
    G. Stennis Watson, James B. Leverenz, Profile of Cognitive Impairment in Parkinson's Disease, Brain Pathology, 2010, 20, 3
  114. 114
    Richard Camicioli, Sumit R. Majumdar, Relationship between mild cognitive impairment and falls in older people with and without Parkinson's disease: 1-Year Prospective Cohort Study, Gait & Posture, 2010, 32, 1, 87

    CrossRef

  115. 115
    Anna Paschali, Lambros Messinis, Odysseas Kargiotis, Velissarios Lakiotis, Zinovia Kefalopoulou, Costantinos Constantoyannis, Panagiotis Papathanasopoulos, Pavlos Vassilakos, SPECT neuroimaging and neuropsychological functions in different stages of Parkinson’s disease, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 6, 1128

    CrossRef

  116. 116
    Dag Aarsland, Martin Wilhelm Kurz, The epidemiology of dementia associated with Parkinson disease, Journal of the Neurological Sciences, 2010, 289, 1-2, 18

    CrossRef

  117. 117
    Dag Aarsland, Martin Wilhelm Kurz, The Epidemiology of Dementia Associated with Parkinson's Disease, Brain Pathology, 2010, 20, 3
  118. 118
    Jean-François Gagnon, Ronald B. Postuma, Steve Joncas, Catherine Desjardins, Véronique Latreille, The Montreal Cognitive Assessment: A screening tool for mild cognitive impairment in REM sleep behavior disorder, Movement Disorders, 2010, 25, 7
  119. 119
    Dag Aarsland, Carmen Janvin, Kolbjørn Brønnick, Dementia, 4th Edition, 2010,

    CrossRef

  120. 120
    Margaret C. Sewell, Andrew Vigario, Mary Sano, Brocklehurst's Textbook of Geriatric Medicine and Gerontology, 2010,

    CrossRef

  121. 121
    David John Burn, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  122. 122
    Flavio Nobili, Giovanni Abbruzzese, Silvia Morbelli, Roberta Marchese, Nicola Girtler, Barbara Dessi, Andrea Brugnolo, Cinzia Canepa, Giorgos Chr. Drosos, Gianmario Sambuceti, Guido Rodriguez, Amnestic mild cognitive impairment in Parkinson's disease: A brain perfusion SPECT study, Movement Disorders, 2009, 24, 3
  123. 123
    Yaroslau Compta, María J. Martí, Naroa Ibarretxe-Bilbao, Carme Junqué, Francesc Valldeoriola, Esteban Muñoz, Mario Ezquerra, Jose Ríos, Eduardo Tolosa, Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease, Movement Disorders, 2009, 24, 15
  124. 124
    Werner Poewe, Clinical measures of progression in Parkinson's disease, Movement Disorders, 2009, 24, S2
  125. 125
    Jae Woo Kim, Sang Myung Cheon, Min Jeong Park, Seong Yeon Kim, Hee Young Jo, Cognitive Impairment in Parkinson's Disease without Dementia: Subtypes and Influences of Age, Journal of Clinical Neurology, 2009, 5, 3, 133

    CrossRef

  126. 126
    Inga Liepelt, Matthias Reimold, Walter Maetzler, Jana Godau, Gerald Reischl, Alexandra Gaenslen, Heinz Herbst, Daniela Berg, Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration—[18F]FDG-PET, Movement Disorders, 2009, 24, 10
  127. 127
    Yoshiyuki Hosokai, Yoshiyuki Nishio, Kazumi Hirayama, Atsushi Takeda, Toshiyuki Ishioka, Yoichi Sawada, Kyoko Suzuki, Yasuto Itoyama, Shoki Takahashi, Hiroshi Fukuda, Etsuro Mori, Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment, Movement Disorders, 2009, 24, 6
  128. 128
    Esen Saka, Bülent Elibol, Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction, Parkinsonism & Related Disorders, 2009, 15, 9, 688

    CrossRef

  129. 129
    Maria C. Rodriguez-Oroz, Pablo Martínez Lage, Jose Sanchez-Mut, Isabel Lamet, Javier Pagonabarraga, Jon B. Toledo, David García-Garcia, Pedro Clavero, Lluis Samaranch, Cecilia Irurzun, Juan M. Matsubara, Jaione Irigoien, Emilia Bescos, Jaime Kulisevsky, Jordi Pérez-Tur, Jose A. Obeso, Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study, Movement Disorders, 2009, 24, 10
  130. 130
    Charles H. Adler, Mild cognitive impairment in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S81

    CrossRef

  131. 131
    Jean-François Gagnon, Mélanie Vendette, Ronald B. Postuma, Catherine Desjardins, Jessica Massicotte-Marquez, Michel Panisset, Jacques Montplaisir, Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease, Annals of Neurology, 2009, 66, 1
  132. 132
    Eugenia Mamikonyan, Paul J. Moberg, Andrew Siderowf, John E. Duda, Tom Ten Have, Howard I. Hurtig, Matthew B. Stern, Daniel Weintraub, Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores, Parkinsonism & Related Disorders, 2009, 15, 3, 226

    CrossRef

  133. 133
    Walter Maetzler, Inga Liepelt, Daniela Berg, Progression of Parkinson's disease in the clinical phase: potential markers, The Lancet Neurology, 2009, 8, 12, 1158

    CrossRef

  134. 134
    Werner Poewe, Philipp Mahlknecht, The clinical progression of Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S28

    CrossRef

  135. 135
    N. K. Archibald, M. P. Clarke, U. P. Mosimann, D. J. Burn, The retina in Parkinson's disease, Brain, 2009, 132, 5, 1128

    CrossRef

  136. 136
    Turi O. Dalaker, Jan P. Larsen, Michael G. Dwyer, Dag Aarsland, Mona K. Beyer, Guido Alves, Kolbjorn Bronnick, Ole-Bjorn Tysnes, Robert Zivadinov, White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease, NeuroImage, 2009, 47, 4, 2083

    CrossRef

  137. 137
    G. Gattellaro, L. Minati, M. Grisoli, C. Mariani, F. Carella, M. Osio, E. Ciceri, A. Albanese, M.G. Bruzzone, White Matter Involvement in Idiopathic Parkinson Disease: A Diffusion Tensor Imaging Study, American Journal of Neuroradiology, 2009, 30, 6, 1222

    CrossRef

  138. 138
    Amy J. Jak, Katherine J. Bangen, Christina E. Wierenga, Lisa Delano-Wood, Jody Corey-Bloom, Mark W. Bondi, Neurobiology of Dementia, 2009,

    CrossRef

  139. 139
    Dag Aarsland, Mona K Beyer, Martin W Kurz, Dementia in Parkinsonʼs disease, Current Opinion in Neurology, 2008, 21, 6, 676

    CrossRef

  140. 140
    W. Poewe, S. Gauthier, D. Aarsland, J. B. Leverenz, P. Barone, D. Weintraub, E. Tolosa, B. Dubois, Diagnosis and management of Parkinson’s disease dementia, International Journal of Clinical Practice, 2008, 62, 10
  141. 141
    In-Uk Song, Joong-Seok Kim, Du-Shin Jeong, Hyun-Joo Song, Kwang-Soo Lee, Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia, Parkinsonism & Related Disorders, 2008, 14, 7, 558

    CrossRef

  142. 142
    M.K. Beyer, D. Aarsland, Grey matter atrophy in early versus late dementia in Parkinson's disease, Parkinsonism & Related Disorders, 2008, 14, 8, 620

    CrossRef

  143. 143
    Roy C. Martin, Ozioma C. Okonkwo, Joni Hill, H. Randall Griffith, Kristen Triebel, Alfred Bartolucci, Anthony P. Nicholas, Ray L. Watts, Natividad Stover, Lindy E. Harrell, David Clark, Daniel C. Marson, Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementia, Movement Disorders, 2008, 23, 13
  144. 144
    Jae Woo Kim, Hee Young Jo, Min Jeong Park, Sang-Myung Cheon, Mild Cognitive Impairment in Parkinson’s Disease, Journal of Movement Disorders, 2008, 1, 1, 19

    CrossRef

  145. 145
    Luca Rozzini, Barbara Vicini Chilovi, Erik Bertoletti, Marta Conti, Ilenia Delrio, Marco Trabucchi, Alessandro Padovani, Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment, International Psychogeriatrics, 2008, 20, 01

    CrossRef

  146. 146
    Karsten Witt, Christine Daniels, Julia Reiff, Paul Krack, Jens Volkmann, Markus O Pinsker, Martin Krause, Volker Tronnier, Manja Kloss, Alfons Schnitzler, Lars Wojtecki, Kai Bötzel, Adrian Danek, Rüdiger Hilker, Volker Sturm, Andreas Kupsch, Elfriede Karner, Günther Deuschl, Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study, The Lancet Neurology, 2008, 7, 7, 605

    CrossRef

  147. 147
    Alexander I. Tröster, Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers, Neuropsychology Review, 2008, 18, 1, 103

    CrossRef

  148. 148
    Myra G. Schneider, Michelle Shardell, Parkinson's disease and functional decline in older Mexican Americans, Parkinsonism & Related Disorders, 2008, 14, 5, 397

    CrossRef

  149. 149
    David J. Gill, Arielle Freshman, Jennifer A. Blender, Bernard Ravina, The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease, Movement Disorders, 2008, 23, 7
  150. 150
    Dag Aarsland, Carmen Janvin, Dementias, 2008,

    CrossRef

  151. 151
    Current awareness in geriatric psychiatry, International Journal of Geriatric Psychiatry, 2007, 22, 5
  152. 152
    John N. Caviness, Erika Driver-Dunckley, Donald J. Connor, Marwan N. Sabbagh, Joseph G. Hentz, Brie Noble, Virgilio Gerald H. Evidente, Holly A. Shill, Charles H. Adler, Defining mild cognitive impairment in Parkinson's disease, Movement Disorders, 2007, 22, 9
  153. 153
    Takahiro Takeda, Toshiki Uchihara, Yoko Mochizuki, Toshio Mizutani, Makoto Iwata, Memory deficits in amyotrophic lateral sclerosis patients with dementia and degeneration of the perforant pathway, Journal of the Neurological Sciences, 2007, 260, 1-2, 225

    CrossRef